Table 1.
Results of initial laboratory tests (September 2019).
| Parameters | Parameter value | Reference interval |
|---|---|---|
| Sodium (mmol/L) | 140 | 135–145 |
| Potassium (mmol/L) | 4.0 | 3.5–5.2 |
| eGFR (mL/min/1.73 m2) | >90 | >90 |
| Fasting glucose (mmol/L) | 3.9 | 3.0–5.5 |
| Albumin (g/L) | 46 | 33–48 |
| Alanine aminotransferase (U/L) | 197 | <51 |
| Aspartate aminotransferase (U/L) | 345 | <36 |
| Alkaline phosphatase (U/L) | 45 | 30–110 |
| γ-Glutamyl transferase (U/L) | 12 | 5–50 |
| Bilirubin (μmol/L) | 6 | 0–20 |
| Corrected calcium (mmol/L) | 2.3 | 2.1–2.6 |
| Magnesium (mmol/L) | 0.95 | 0.7–1.1 |
| Phosphate (mmol/L) | 1.25 | 0.75–1.5 |
| Holotranscobalamin (pmol/L) | 42.8 | 50.1–165 |
| Folate (nmol/L) | 19.3 | 8.83–60.8 |
| Creatine kinase (U/L) | 20,804 | 45–250 |
| Total cholesterol (mmol/L) | 7.9 | 3–5.5 |
| Free T4 (pmol/L) | 1.6 | 12–22 |
| Free T3 (pmol/L) | <1.5 | 3.1–6.8 |
| TSH (mIU/L) | 405.5 | 0.27–4.2 |
| Haemoglobin (g/L) | 142 | 130–180 |
| Platelets (×109/L) | 270 | 150–450 |
| White cell count (×109/L) | 7.67 | 3.5–11 |
| Thyroid peroxidase (TPO) antibodies (IU/mL) | >600 | ≤35 |
| Thyroglobulin antibodies (IU/mL) | 152 | 0–115 |
| Intrinsic factor antibodies | Negative | |
| Gastric parietal cell antibodies | Negative | |
| Antinuclear antibodies | Negative | |
| Double stranded DNA antibodies | Negative | |
| ENA screen | Not detected | |
| Myositis antibodies screen | Not detected | |
| Antimyelin-associated glycoprotein | Not detected | |
| Acetylcholine receptor antibodies | Not detected |
Values in bold represent abnormal results